Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Indolent Non-Hodgkin Lymphoma × ibrutinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 6 Lymphoma, Mantle-Cell 4 Lymphoma, Large B-Cell, Diffuse 4 Waldenstrom Macroglobulinemia 2 Neoplasms 2 Recurrence 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Leukemia, Myeloid, Acute 1 Indolent Non-Hodgkin Lymphoma 1 Hepatitis B, Chronic 1 Gastrooesophageal Cancer 1

Interventions

obinutuzumab 1 ibrutinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02689869 2021-05-07

Alternative

Ludwig-Maximilians - University of Munich

Phase 2 Unknown

Indolent Non-Hodgkin Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡